Analyis of a phase III trial looked at Bortezomib in combination with chemotherapy for first line treatment of MCL in East Asian patients.
Home / Resource Library / Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma